Current Issue
March 2026 — Volume 1, Issue 1
Table of Contents
- Clinical Research ARPA-H Develops FDA-Authorized AI Agents for Clinical UseRobert Kim March 20, 2026
- Clinical Research FDA Approves High-Dose Wegovy 7.2mg for Obesity in 2026Sarah Tanaka March 20, 2026
- Clinical Research Medicare Chief: TrumpRx Is Narrow in Scope, Not a Full FixKeala Nakamura March 20, 2026
- Clinical Research Cancer Cells Surface Proteins: New Immunotherapy Targets 2026Priya Patel March 18, 2026
- Clinical Research MedPAC 2026: $76B Medicare Advantage Overpayment WarningSarah Tanaka March 18, 2026
- Clinical Research Trump Drug Pricing & GSK Asthma Inhaler Controversy 2026Keala Nakamura March 18, 2026
- Clinical Research Aldeyra Therapeutics FDA Review: Red Flags & Short SellersJames Liu March 17, 2026
- Clinical Research PHILA Trial: Pyrotinib Survival Results in HER2+ Breast CancerHawaii Medical Journal March 17, 2026
- Clinical Research Oral Obesity Pill Phase 2 Results & Cholesterol Guidelines 2026Keala Nakamura March 17, 2026
- Medical Technology How Digital Marketplaces Are Reshaping Lab Procurement in 2026Priya Patel March 16, 2026
- Clinical Research Tourette Syndrome: Why Media Distortion Harms Clinical CareRobert Kim March 16, 2026
- Clinical Research UK Government Plans Space-Based Pharmaceutical ManufacturingPriya Patel March 16, 2026
- Clinical Research Regulating Invasive Cosmetic Procedures to Reduce HarmSarah Tanaka March 16, 2026
-
- Clinical Research Updated NICE Guidance: Chronic Heart Failure in AdultsMichael O'Connor March 15, 2026
- Clinical Research NHS Advice & Guidance Referral Rules Put Patients at RiskHawaii Medical Journal March 15, 2026
-
- Clinical Research Best Drugs to Prevent Postoperative Delirium in Older AdultsPriya Patel March 14, 2026
-
- Clinical Research Lancet Correction: Prostate Cancer Radiotherapy Meta-AnalysisSarah Tanaka March 13, 2026
Editor's Picks
Most Cited
- ARPA-H Develops FDA-Authorized AI Agents for Clinical Use 37 citations
- FDA Approves High-Dose Wegovy 7.2mg for Obesity in 2026 11 citations
- Medicare Chief: TrumpRx Is Narrow in Scope, Not a Full Fix 13 citations
- Cancer Cells Surface Proteins: New Immunotherapy Targets 2026 33 citations
- MedPAC 2026: $76B Medicare Advantage Overpayment Warning 5 citations
For Authors
Hawaii Medical Journal welcomes research submissions, case reports, and correspondence.
Submit a ManuscriptArchives
Browse past issues